Natia Esiashvili

Suggest Changes
Learn More
PURPOSE To evaluate the value of adding involved field radiotherapy (IFRT) to patients with relapsed/refractory Hodgkin lymphoma (HL) undergoing high-dose chemotherapy (HDCT) and stem cell(More)